P2RY4 and hepatocellular carcinoma: HCC patients with C5 and LPAR6 alterations showed low overall survival (Figure 6(a)), and HCC patients with SSTR5, P2RY4, LPAR6, and GPR68 alterations showed low disease-free survival (Figure 6(b)).